Knockdown of arginase I restores NO signaling in the vasculature of old rats

Anthony R. White, Sungwoo Ryoo, Dechun Li, Hunter C. Champion, Jochen Steppan, Danming Wang, Daniel Nyhan, Artin A. Shoukas, Joshua Hare, Dan E. Berkowitz

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

Arginase, expressed in endothelial cells and upregulated in aging blood vessels, competes with NO synthase (NOS) for L-arginine, thus modulating vasoreactivity and attenuating NO signaling. Moreover, arginase inhibition restores endothelial NOS signaling and L-arginine responsiveness in old rat aorta. The arginase isoform responsible for modulating NOS, however, remains unknown. Because isoform-specific arginase inhibitors are unavailable, we used an antisense (AS) oligonucleotide approach to knockdown arginase I (Arg I). Western blot and quantitative PCR confirmed that Arg I is the predominant isoform expressed in endothelialized aortic rings and is upregulated in old rats compared with young. Aortic rings from 22-month-old rats were incubated for 24 hours with sense (S), AS oligonucleotides, or medium alone (C). Immunohistochemistry, immunoblotting, and enzyme assay confirmed a significant knockdown of Arg I protein and arginase activity in AS but not S or C rings. Conversely, calcium-dependent NOS activity and vascular metabolites of NO was increased in AS versus S or C rings. Acetylcholine (endothelial-dependent) vasorelaxant responses were enhanced in AS versus S or C treated rings. In addition, 1H-oxadiazolo quinoxalin-1-one (10 μmol/L), a soluble guanylyl cyclase inhibitor, increased the phenylephrine response in AS compared with S and C rings suggesting increased NO bioavailability. Finally, L-arginine (0.1 mmol/L)-induced relaxation was increased in AS versus C rings. These data support our hypothesis that Arg I plays a critical role in the pathobiology of age-related endothelial dysfunction. AS oligonucleotides may, therefore, represent a novel therapeutic strategy against age-related vascular endothelial dysfunction.

Original languageEnglish
Pages (from-to)245-251
Number of pages7
JournalHypertension
Volume47
Issue number2
DOIs
StatePublished - Feb 1 2006
Externally publishedYes

Fingerprint

Arginase
Nitric Oxide Synthase
Antisense Oligonucleotides
Blood Vessels
Arginine
Protein Isoforms
Quinoxalines
Enzyme Assays
Phenylephrine
Vasodilator Agents
Immunoblotting
Biological Availability
Acetylcholine
Aorta
Endothelial Cells
Western Blotting
Immunohistochemistry
Calcium
Polymerase Chain Reaction

Keywords

  • Aging
  • Atherosclerosis
  • Endothelium
  • Nitric oxide

ASJC Scopus subject areas

  • Internal Medicine

Cite this

White, A. R., Ryoo, S., Li, D., Champion, H. C., Steppan, J., Wang, D., ... Berkowitz, D. E. (2006). Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension, 47(2), 245-251. https://doi.org/10.1161/01.HYP.0000198543.34502.d7

Knockdown of arginase I restores NO signaling in the vasculature of old rats. / White, Anthony R.; Ryoo, Sungwoo; Li, Dechun; Champion, Hunter C.; Steppan, Jochen; Wang, Danming; Nyhan, Daniel; Shoukas, Artin A.; Hare, Joshua; Berkowitz, Dan E.

In: Hypertension, Vol. 47, No. 2, 01.02.2006, p. 245-251.

Research output: Contribution to journalArticle

White, AR, Ryoo, S, Li, D, Champion, HC, Steppan, J, Wang, D, Nyhan, D, Shoukas, AA, Hare, J & Berkowitz, DE 2006, 'Knockdown of arginase I restores NO signaling in the vasculature of old rats', Hypertension, vol. 47, no. 2, pp. 245-251. https://doi.org/10.1161/01.HYP.0000198543.34502.d7
White AR, Ryoo S, Li D, Champion HC, Steppan J, Wang D et al. Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension. 2006 Feb 1;47(2):245-251. https://doi.org/10.1161/01.HYP.0000198543.34502.d7
White, Anthony R. ; Ryoo, Sungwoo ; Li, Dechun ; Champion, Hunter C. ; Steppan, Jochen ; Wang, Danming ; Nyhan, Daniel ; Shoukas, Artin A. ; Hare, Joshua ; Berkowitz, Dan E. / Knockdown of arginase I restores NO signaling in the vasculature of old rats. In: Hypertension. 2006 ; Vol. 47, No. 2. pp. 245-251.
@article{062c896b402f44b89d7e2592714226e7,
title = "Knockdown of arginase I restores NO signaling in the vasculature of old rats",
abstract = "Arginase, expressed in endothelial cells and upregulated in aging blood vessels, competes with NO synthase (NOS) for L-arginine, thus modulating vasoreactivity and attenuating NO signaling. Moreover, arginase inhibition restores endothelial NOS signaling and L-arginine responsiveness in old rat aorta. The arginase isoform responsible for modulating NOS, however, remains unknown. Because isoform-specific arginase inhibitors are unavailable, we used an antisense (AS) oligonucleotide approach to knockdown arginase I (Arg I). Western blot and quantitative PCR confirmed that Arg I is the predominant isoform expressed in endothelialized aortic rings and is upregulated in old rats compared with young. Aortic rings from 22-month-old rats were incubated for 24 hours with sense (S), AS oligonucleotides, or medium alone (C). Immunohistochemistry, immunoblotting, and enzyme assay confirmed a significant knockdown of Arg I protein and arginase activity in AS but not S or C rings. Conversely, calcium-dependent NOS activity and vascular metabolites of NO was increased in AS versus S or C rings. Acetylcholine (endothelial-dependent) vasorelaxant responses were enhanced in AS versus S or C treated rings. In addition, 1H-oxadiazolo quinoxalin-1-one (10 μmol/L), a soluble guanylyl cyclase inhibitor, increased the phenylephrine response in AS compared with S and C rings suggesting increased NO bioavailability. Finally, L-arginine (0.1 mmol/L)-induced relaxation was increased in AS versus C rings. These data support our hypothesis that Arg I plays a critical role in the pathobiology of age-related endothelial dysfunction. AS oligonucleotides may, therefore, represent a novel therapeutic strategy against age-related vascular endothelial dysfunction.",
keywords = "Aging, Atherosclerosis, Endothelium, Nitric oxide",
author = "White, {Anthony R.} and Sungwoo Ryoo and Dechun Li and Champion, {Hunter C.} and Jochen Steppan and Danming Wang and Daniel Nyhan and Shoukas, {Artin A.} and Joshua Hare and Berkowitz, {Dan E.}",
year = "2006",
month = "2",
day = "1",
doi = "10.1161/01.HYP.0000198543.34502.d7",
language = "English",
volume = "47",
pages = "245--251",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Knockdown of arginase I restores NO signaling in the vasculature of old rats

AU - White, Anthony R.

AU - Ryoo, Sungwoo

AU - Li, Dechun

AU - Champion, Hunter C.

AU - Steppan, Jochen

AU - Wang, Danming

AU - Nyhan, Daniel

AU - Shoukas, Artin A.

AU - Hare, Joshua

AU - Berkowitz, Dan E.

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Arginase, expressed in endothelial cells and upregulated in aging blood vessels, competes with NO synthase (NOS) for L-arginine, thus modulating vasoreactivity and attenuating NO signaling. Moreover, arginase inhibition restores endothelial NOS signaling and L-arginine responsiveness in old rat aorta. The arginase isoform responsible for modulating NOS, however, remains unknown. Because isoform-specific arginase inhibitors are unavailable, we used an antisense (AS) oligonucleotide approach to knockdown arginase I (Arg I). Western blot and quantitative PCR confirmed that Arg I is the predominant isoform expressed in endothelialized aortic rings and is upregulated in old rats compared with young. Aortic rings from 22-month-old rats were incubated for 24 hours with sense (S), AS oligonucleotides, or medium alone (C). Immunohistochemistry, immunoblotting, and enzyme assay confirmed a significant knockdown of Arg I protein and arginase activity in AS but not S or C rings. Conversely, calcium-dependent NOS activity and vascular metabolites of NO was increased in AS versus S or C rings. Acetylcholine (endothelial-dependent) vasorelaxant responses were enhanced in AS versus S or C treated rings. In addition, 1H-oxadiazolo quinoxalin-1-one (10 μmol/L), a soluble guanylyl cyclase inhibitor, increased the phenylephrine response in AS compared with S and C rings suggesting increased NO bioavailability. Finally, L-arginine (0.1 mmol/L)-induced relaxation was increased in AS versus C rings. These data support our hypothesis that Arg I plays a critical role in the pathobiology of age-related endothelial dysfunction. AS oligonucleotides may, therefore, represent a novel therapeutic strategy against age-related vascular endothelial dysfunction.

AB - Arginase, expressed in endothelial cells and upregulated in aging blood vessels, competes with NO synthase (NOS) for L-arginine, thus modulating vasoreactivity and attenuating NO signaling. Moreover, arginase inhibition restores endothelial NOS signaling and L-arginine responsiveness in old rat aorta. The arginase isoform responsible for modulating NOS, however, remains unknown. Because isoform-specific arginase inhibitors are unavailable, we used an antisense (AS) oligonucleotide approach to knockdown arginase I (Arg I). Western blot and quantitative PCR confirmed that Arg I is the predominant isoform expressed in endothelialized aortic rings and is upregulated in old rats compared with young. Aortic rings from 22-month-old rats were incubated for 24 hours with sense (S), AS oligonucleotides, or medium alone (C). Immunohistochemistry, immunoblotting, and enzyme assay confirmed a significant knockdown of Arg I protein and arginase activity in AS but not S or C rings. Conversely, calcium-dependent NOS activity and vascular metabolites of NO was increased in AS versus S or C rings. Acetylcholine (endothelial-dependent) vasorelaxant responses were enhanced in AS versus S or C treated rings. In addition, 1H-oxadiazolo quinoxalin-1-one (10 μmol/L), a soluble guanylyl cyclase inhibitor, increased the phenylephrine response in AS compared with S and C rings suggesting increased NO bioavailability. Finally, L-arginine (0.1 mmol/L)-induced relaxation was increased in AS versus C rings. These data support our hypothesis that Arg I plays a critical role in the pathobiology of age-related endothelial dysfunction. AS oligonucleotides may, therefore, represent a novel therapeutic strategy against age-related vascular endothelial dysfunction.

KW - Aging

KW - Atherosclerosis

KW - Endothelium

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=31944447852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31944447852&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000198543.34502.d7

DO - 10.1161/01.HYP.0000198543.34502.d7

M3 - Article

VL - 47

SP - 245

EP - 251

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -